STRS Ohio’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-106,900
| Closed | -$285K | – | 2092 |
|
|
2022
Q1 | $285K | Hold |
106,900
| – | – | ﹤0.01% | 1613 |
|
|
2021
Q4 | $462K | Hold |
106,900
| – | – | ﹤0.01% | 1505 |
|
|
2021
Q3 | $544K | Sell |
106,900
-8,900
| -8% | -$45.3K | ﹤0.01% | 1477 |
|
|
2021
Q2 | $733K | Buy |
115,800
+26,900
| +30% | +$170K | ﹤0.01% | 1409 |
|
|
2021
Q1 | $687K | Hold |
88,900
| – | – | ﹤0.01% | 1431 |
|
|
2020
Q4 | $582K | Buy |
88,900
+11,700
| +15% | +$76.6K | ﹤0.01% | 1387 |
|
|
2020
Q3 | $513K | Buy |
77,200
+21,100
| +38% | +$140K | ﹤0.01% | 1315 |
|
|
2020
Q2 | $467K | Buy |
56,100
+4,600
| +9% | +$38.3K | ﹤0.01% | 1354 |
|
|
2020
Q1 | $395K | Hold |
51,500
| – | – | ﹤0.01% | 1311 |
|
|
2019
Q4 | $427K | Sell |
51,500
-8,400
| -14% | -$69.6K | ﹤0.01% | 1499 |
|
|
2019
Q3 | $442K | Hold |
59,900
| – | – | ﹤0.01% | 1349 |
|
|
2019
Q2 | $672K | Buy |
59,900
+4,200
| +8% | +$47.1K | ﹤0.01% | 1043 |
|
|
2019
Q1 | $598K | Buy |
55,700
+17,800
| +47% | +$191K | ﹤0.01% | 1152 |
|
|
2018
Q4 | $572K | Hold |
37,900
| – | – | ﹤0.01% | 1126 |
|
|
2018
Q3 | $701K | Hold |
37,900
| – | – | ﹤0.01% | 1156 |
|
|
2018
Q2 | $866K | Buy |
37,900
+10,800
| +40% | +$247K | ﹤0.01% | 992 |
|
|
2018
Q1 | $770K | Sell |
27,100
-9,400
| -26% | -$267K | ﹤0.01% | 1041 |
|
|
2017
Q4 | $770K | Sell |
36,500
-4,100
| -10% | -$86.5K | ﹤0.01% | 1032 |
|
|
2017
Q3 | $737K | Sell |
40,600
-7,000
| -15% | -$127K | ﹤0.01% | 1108 |
|
|
2017
Q2 | $737K | Buy |
47,600
+35,600
| +297% | +$551K | ﹤0.01% | 1039 |
|
|
2017
Q1 | $207K | Buy |
+12,000
| New | +$207K | ﹤0.01% | 1529 |
|
|
2016
Q4 | – | Sell |
-2,400
| Closed | -$37K | – | 1946 |
|
|
2016
Q3 | $37K | Sell |
2,400
-100
| -4% | -$1.54K | ﹤0.01% | 1800 |
|
|
2016
Q2 | $25K | Hold |
2,500
| – | – | ﹤0.01% | 1849 |
|
|
2016
Q1 | $32K | Hold |
2,500
| – | – | ﹤0.01% | 1801 |
|
|
2015
Q4 | $52K | Buy |
+2,500
| New | +$52K | ﹤0.01% | 1787 |
|